To hear about similar clinical trials, please enter your email below
Trial Title:
A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients
NCT ID:
NCT06009549
Condition:
Metastatic Prostate Cancer
Conditions: Official terms:
Prostatic Neoplasms
Conditions: Keywords:
metastatic prostate cancer
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Taking part in clinical trials usually favors a particular demographic group. But there
is limited research available to explain what trial attributes affect the completion of
these specific demographic groups.
This research will admit a wide range of data on the clinical study experience of
metastatic prostate cancer patients to determine which factors prevail in limiting a
patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to
check for recurring trends which might yield insights for the sake of future patients
with metastatic prostate cancer.
Criteria for eligibility:
Study pop:
Patients with metastatic prostate cancer who are actively considering enrolling in a
clinical study, but have not yet completed enrollment and randomization.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Patient is at least 18 years of age
- Diagnosis of metastatic prostate cancer
- Ability to understand and the willingness to sign a written informed consent
document
Exclusion Criteria:
- Enrolled in another research study
- Patients with psychiatric illness/social situations that would limit compliance with
study requirements
- Inability to provide written informed consent
Gender:
Male
Gender based:
Yes
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Power Life Sciences
Address:
City:
San Francisco
Zip:
94107
Country:
United States
Contact:
Last name:
Michael B Gill
Phone:
415-900-4227
Email:
https://www.withpower.com/contact-us@withpower.com
Start date:
September 2024
Completion date:
September 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06009549
